Discovery and Development of Small Molecule SHIP Phosphatase Modulators
Year: 2013
Type: review
Abstract: Inositol phospholipids play an important role in the transfer of signaling information across the cell membrane in eukaryotes. These signals are often governed by the phosphorylation patterns on the inositols, which are mediated by a number of inositol kinases and phosphatases. The src homology 2 (SH2) containing inositol 5-phosphatase (SHIP) plays a central role in these processes, influencing signals delivered through the PI3K/Akt/mTOR pathway. SHIP modulation by small molecules has been implicated as a treatment in a number of human disease states, including cancer, inflammatory diseases, diabetes, atherosclerosis, and Alzheimer's disease. In addition, alteration of SHIP phosphatase activity may provide a means to facilitate bone marrow transplantation and increase blood cell production. This review discusses the cellular signaling pathways and protein-protein interactions that provide the molecular basis for targeting the SHIP enzyme in these disease states. In addition, a comprehensive survey of small molecule modulators of SHIP1 and SHIP2 is provided, with a focus on the structure, potency, selectivity, and solubility properties of these compounds.
Source: Medicinal Research Reviews
DOI: 10.1002/med.21305
Institutions: Syracuse University, SUNY Upstate Medical University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: SHIP1, SHIP2, small molecule modulators, inositol phospholipids, PI3K/AKT/mTOR pathway, protein-protein interaction, drug discovery, structure-activity relationship, cancer, inflammatory diseases, diabetes mellitus, atherosclerosis, Alzheimer's disease, bone marrow transplantation, hematopoiesis
Open Access status: green
OpenAlex ID: W1520430411
